electroCore to Participate at Upcoming Investor Conferences
September 23, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Sept. 23, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will...
electroCore Announces Peter Cuneo as Board Chairman
September 20, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Sept. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Board of Directors has appointed Peter...
electroCore Announces New Patent Expanding Claims Related to Delivery of Non-Invasive Vagus Nerve Stimulation Therapy Using Mobile Devices
September 15, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Sept. 15, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark...
electroCore Announces 510(k) Clearance of gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Paroxysmal Hemicrania and Hemicrania Continua
September 14, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Sept. 14, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that on September 10, 2021 the company...
electroCore to Present at the HC Wainwright 23rd Annual Global Investment Conference
August 31, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Aug. 31, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will...
electroCore Announces New Reseller Agreement with Red One Medical Devices, LLC.
August 24, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Aug. 24, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced a reseller agreement with Red One Medical...
Study of Non-Invasive Vagus Nerve Stimulation (nVNS) Shows Improvement in PTSD Symptoms and Decreased Inflammatory Response to Stress
August 10, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Aug. 10, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer reviewed manuscript,...
electroCore Announces Second Quarter 2021 Financial Results
August 05, 2021 16:01 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Aug. 05, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced second quarter 2021 financial results and provided an...
electroCore Announces Publication in PharmacoEconomics Reiterating Economic Benefits of gammaCore for Cluster Headache Outlined by The National Institute for Health and Care Excellence (NICE) Medical Technologies Guidance
August 04, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Aug. 04, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company (the Company), today announced the release of an article entitled...
electroCore to Present at the Canaccord Genuity Growth Conference
August 02, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Aug. 02, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will...